NO2523946T3 - - Google Patents

Info

Publication number
NO2523946T3
NO2523946T3 NO11700612A NO11700612A NO2523946T3 NO 2523946 T3 NO2523946 T3 NO 2523946T3 NO 11700612 A NO11700612 A NO 11700612A NO 11700612 A NO11700612 A NO 11700612A NO 2523946 T3 NO2523946 T3 NO 2523946T3
Authority
NO
Norway
Application number
NO11700612A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2523946T3 publication Critical patent/NO2523946T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO11700612A 2010-01-14 2011-01-13 NO2523946T3 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10000282A EP2345646A1 (en) 2010-01-14 2010-01-14 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
EP11700612.2A EP2523946B1 (en) 2010-01-14 2011-01-13 Tricyclic sesquiterpene lactones for used in the treatment of obesity and related diseases and non-therapeutic treatable conditions
PCT/EP2011/000110 WO2011085979A1 (en) 2010-01-14 2011-01-13 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions

Publications (1)

Publication Number Publication Date
NO2523946T3 true NO2523946T3 (no) 2018-02-17

Family

ID=42727406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO11700612A NO2523946T3 (no) 2010-01-14 2011-01-13

Country Status (9)

Country Link
US (2) US20130023586A1 (no)
EP (3) EP2345646A1 (no)
DK (1) DK2523946T3 (no)
ES (1) ES2652595T3 (no)
HU (1) HUE037455T2 (no)
NO (1) NO2523946T3 (no)
PL (1) PL2523946T3 (no)
PT (1) PT2523946T (no)
WO (1) WO2011085979A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013103384A1 (en) 2012-01-06 2013-07-11 Elcelyx Therapeutics, Inc. Biguanide compositions and methods of treating metabolic disorders
HUE051738T2 (hu) 2011-01-07 2021-03-29 Anji Pharma Us Llc Kemoszenzoros receptorligandum-alapú terápiák
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
ITMI20111670A1 (it) * 2011-09-16 2013-03-17 Indena Spa Estratti di cynara scolimus per il trattamento di dislipidemie
BR112014016810A8 (pt) 2012-01-06 2017-07-04 Elcelyx Therapeutics Inc composições e métodos para tratamento de distúrbios metabólicos
JP6026639B2 (ja) * 2012-04-02 2016-11-16 ソンギュン バイオテック カンパニー リミテッドＳｕｎｇ Ｋｙｕｎ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． フジバカマ属の抽出物を含有する骨代謝疾患の予防及び治療用組成物及びその製造方法
WO2013171100A1 (en) 2012-05-16 2013-11-21 Joachim Hans Polyhydroxylated pentacyclic triterpene acids as hmg-coa reductase inhibitors
AR091739A1 (es) 2012-07-11 2015-02-25 Elcelyx Therapeutics Inc Composiciones y metodos para reducir el riesgo cardiometabolico
KR101378433B1 (ko) * 2012-11-05 2014-03-27 초당약품공업 주식회사 세스퀴터핀 락톤계 위장 질환 치료용 의약 조성물
KR101378431B1 (ko) * 2012-11-05 2014-03-27 초당약품공업 주식회사 세스퀴터핀 락톤계 위장 질환 치료용 의약 조성물
US20140193498A1 (en) 2013-01-05 2014-07-10 Elcelyx Therapeutics, Inc. Compositions and Methods for Treating Metabolic Disorders
CN104016952B (zh) * 2013-02-28 2016-05-18 东北林业大学 一种倍半萜活性成分及其制备方法与应用
FR3011180B1 (fr) * 2013-10-01 2017-01-06 Laboratoires De Biologie Vegetale Yves Rocher Utilisation d'un extrait d'artemisia montana dans une composition cosmetique amincissante
KR101926075B1 (ko) * 2017-01-05 2018-12-06 동신대학교산학협력단 명월초에서 분리한 화합물 등을 이용한 항당뇨 조성물
CN107118188A (zh) * 2017-05-09 2017-09-01 中国科学院新疆理化技术研究所 天山雪莲种子中的倍半萜内酯类化合物及其制备方法
CN108003174A (zh) * 2017-12-18 2018-05-08 南开大学 一种倍半萜衍生物的晶型及其制备方法与用途
KR102406792B1 (ko) * 2019-12-20 2022-06-10 주식회사 봄프렌즈 다이어트 기능성 개과 동물용 사료 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH617326A5 (no) 1975-12-04 1980-05-30 Siegfried Ag
EP1175901B1 (en) * 1999-04-15 2006-05-31 Kaneka Corporation Peroxisome activator-responsive receptor agonists
US6530886B1 (en) 1999-10-08 2003-03-11 Tanita Corporation Method and apparatus for measuring subcutaneous fat using ultrasonic wave
ATE345126T1 (de) * 2001-08-15 2006-12-15 Meiji Dairies Corp Sesquiterpenoid-derivate mit adipozytendifferenzierungshemmender wirkung
KR100469612B1 (ko) * 2003-02-05 2005-02-02 주식회사 싸이제닉 흰씀바귀로부터 추출된 세스퀴테르펜 락톤계 화합물 및이를 함유하는 심혈관 질환 및 암 치료용 조성물
KR100552109B1 (ko) * 2003-02-05 2006-02-14 학교법인 경희대학교 흰씀바귀로부터 추출된 세스퀴테르펜 락톤 화합물을 함유하는 심혈관 질환 예방 및 치료용 조성물
KR100572621B1 (ko) 2003-03-19 2006-04-24 한국 한의학 연구원 비만 및 성인병 치료용 조성물
WO2004096252A1 (en) 2003-04-25 2004-11-11 Primavera Biosciences, Inc. Compositions and methods for weight loss
JP2006206532A (ja) 2005-01-31 2006-08-10 Ichimaru Pharcos Co Ltd ＮＦ−κＢ活性化抑制剤
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
ES2323815T3 (es) * 2007-03-07 2009-07-24 Indena S.P.A. Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad.
JP2008231031A (ja) * 2007-03-20 2008-10-02 Arkray Inc デヒドロエピアンドロステロン産生促進剤およびその用途
WO2009005115A1 (ja) * 2007-07-03 2009-01-08 Nisshin Pharma Inc. 脂肪細胞の小型化促進用組成物
KR100905419B1 (ko) * 2008-09-11 2009-07-02 연세대학교 산학협력단 세스퀴테르펜 유도체의 용도

Also Published As

Publication number Publication date
US20200055835A1 (en) 2020-02-20
WO2011085979A1 (en) 2011-07-21
ES2652595T3 (es) 2018-02-05
EP2523946A1 (en) 2012-11-21
PL2523946T3 (pl) 2018-02-28
EP3260449A1 (en) 2017-12-27
DK2523946T3 (en) 2018-01-08
EP2345646A1 (en) 2011-07-20
EP2523946B1 (en) 2017-09-20
PT2523946T (pt) 2017-12-13
US20130023586A1 (en) 2013-01-24
HUE037455T2 (hu) 2018-08-28
WO2011085979A4 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
BR112013013385A2 (no)
BR112013008959A2 (no)
BR112012031500A2 (no)
BR112012029986A2 (no)
BR112012028408A2 (no)
BR112012026492A2 (no)
BR112012019354A2 (no)
BR112012002126A2 (no)
BR112012026946A2 (no)
BR112012017960A2 (no)
BR112013006400A2 (no)
BR112012031826A2 (no)
BR112012016456A2 (no)
BR112012027015A2 (no)
NO2523946T3 (no)
BR112012027945A2 (no)
BR112013010949A2 (no)
BR112013003284A2 (no)
BR112013002646A2 (no)
BR112012026403A2 (no)
BR112013012726A2 (no)
BR112013006825A2 (no)
BR112012028859A2 (no)
BR112012016895A2 (no)
BR112013007728A2 (no)